Journal
CTS-CLINICAL AND TRANSLATIONAL SCIENCE
Volume 4, Issue 3, Pages 204-209Publisher
WILEY-BLACKWELL
DOI: 10.1111/j.1752-8062.2011.00280.x
Keywords
-
Categories
Funding
- Indiana University-Purdue University, Indianapolis Signature Center
- Indiana University Center for Pharmacogenetics and Therapeutics Research in Maternal and Child Health
- U.S. Food and Drug Administration, Office of Women's Health
- National Institute for Child Health and Human Development, National Institutes of Health
Ask authors/readers for more resources
To address provider struggles to provide evidence-based, rational drug therapy to pregnant women, this third Conference was convened to highlight the current progress and research in the field. Speakers from academic centers, industry, and governmental institutions spoke about: the Food and Drug Administration's role in pregnancy pharmacology and the new labeling initiative; drug registries in pregnancy; the pharmacist's role in medication use in pregnancy; therapeutic areas such as preterm labor, gestational diabetes, nausea and vomiting in pregnancy, and hypertension; breast-feeding and medications; ethical challenges for consent in pregnancy drug studies; the potential for cord blood banks; and concerns about the fetus when studying drugs in pregnancy. The Conference highlighted several areas of collaboration within the current Obstetrics Pharmacology Research Units Network and hoped to educate providers, researchers, and agencies with the common goal to improve the ability to safely and effectively use individualized pharmacotherapy in pregnancy. Clin Trans Sci 2011; Volume 4: 204-209
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available